This 2012 review article, published in Current Pharmaceutical Design, explores the involvement of oxidative stress in the pathophysiology of depressive disorders. The authors discuss how an imbalance between reactive oxygen species (ROS) production and antioxidant defenses can lead to neuronal damage, contributing to the development and progression of depression. The
